Z-1797-2018 Class II Terminated
FDA device recall Z-1797-2018 was initiated by Diagnostic Hybrids, Inc. on Jul 14, 2016 and is designated Class II. Reason for recall: There is a possibility of low volume and/or leaking standard bottles. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 1004.
Recall details
- Product Type
- Devices
- Report Date
- May 16, 2018
- Initiation Date
- Jul 14, 2016
- Termination Date
- Aug 28, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1004
Product description
MicroVue BAP EIA, Model 8012, provides a quantitative measure of bone-specific alkaline phosphatase (BAP) activity in serum.
Reason for recall
There is a possibility of low volume and/or leaking standard bottles.
Distribution pattern
The products were distributed to the following US states: CA, CT, GA, IL, KY, MA, MD, MO, PA, TX, WA, and WI. The products were distributed to the following foreign countries: Australia, Brazil, Canada, China, Costa Rica, India, Japan, Mexico, The Philippines, Russia, South Korea, South Africa, Switzerland, and Uruguay.
Code information
Lot 067850
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1797-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026